Author of the publication

In Silico Biosimulation of Isoflurane Effects on Brain Using Transcriptome-To-Metabolome™ Technology: Anesthesia Effects on Rat Amygdala & Cortex Metabolism.

, and . IJKDB, 5 (1): 1-10 (2015)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Alzheimer's and Parkinson's Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors., , , and . IJKDB, 7 (2): 68-82 (2017)Mitochondrial Pyruvate Carrier 1 and 2 Heterodimer, In Silico, Models of Plant and Human Complexes: A Comparison of Structure and Transporter Binding Properties., , and . IJKDB, 7 (2): 11-42 (2017)Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease., , , , , , , , and . IJKDB, 2 (2): 1-18 (2011)Modeling non-clinical and clinical drug tests in Gaucher disease., , , and . EMBC, page 1434-1438. IEEE, (2016)Biomarkers from biosimulations: Transcriptome-to-reactome™ Technology for individualized medicine., , , and . EMBC, page 3452-3455. IEEE, (2014)Integrating -omics information with biosimulations to assist diagnosis and treatment of diabetes mellitus in silico., , , and . BHI, page 53-56. IEEE, (2017)MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer: PPARγ Activating and Sparing TZDs as Therapeutics., , , , and . IJKDB, 7 (2): 43-67 (2017)In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease - Modeling Brain Aging and Disease., , , , , , , , and . ICDM Workshops, page 1064-1070. IEEE Computer Society, (2011)Integrating information on genomics, transcriptomics, proteomics, and metabolomics into biosimulations for individualized personalized medicine., and . BHI, page 312-315. IEEE, (2016)Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET: Transcriptome-To-Reactome™ Biosimulation of Neurons., , , , and . IJKDB, 5 (1): 24-45 (2015)